Literature DB >> 19151234

The neurology of HTLV-1 infection.

Sarah A Cooper1, Maarten Schim van der Loeff, Graham P Taylor.   

Abstract

HTLV-1 is a significant global health problem but remains largely confined to endemic areas and risk groups. However, increasing migration may mean that the virus will be encountered more frequently in areas traditionally thought of as virtually free of HTLV-1. In this review we discuss the epidemiology, transmission, clinical features, diagnosis and treatment of HTLV-1, focussing specifically on the neurological manifestations. We highlight the circumstances in which HTLV-1 should be suspected and outline the current understanding of HTLV-1-associated myelopathy and other neurological presentations.

Entities:  

Mesh：

Year:  2009        PMID： 19151234     DOI： 10.1136/jnnp.2008.167155

Source DB:  PubMed          Journal:  Pract Neurol        ISSN： 1474-7758


  18 in total

Review 1.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 2.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

4.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

5.  Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.

Authors:  Reza Boostani; Mina Khodabandeh; Seyyed Abdolrahim Rezaee; Houshang Rafatpanah; Sanaz Ahmadi Ghezeldasht; Zohreh Vahidi; Zahra Baghestani
Journal:  J Neurovirol       Date:  2021-04-20       Impact factor: 2.643

6.  Expanding the etiologic spectrum of spastic ataxia syndrome: chronic infection with human T lymphotropic virus type 1.

Authors:  Karolina Af Edhom; Christer Lidman; Tobias Granberg; Graham P Taylor; Martin Paucar
Journal:  J Neurovirol       Date:  2021-03-22       Impact factor: 2.643

7.  Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?

Authors:  Matheus Tannus; Davi Tanajura; Michael A Sundberg; Paulo Oliveira; Neviton Castro; André Muniz Santos
Journal:  Case Rep Med       Date:  2011-04-13

Review 8.  Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs).

Authors:  Benoit Barbeau; Jean-Michel Mesnard
Journal:  Viruses       Date:  2011-05-05       Impact factor: 5.048

9.  Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP.

Authors:  Davi Tanajura Costa; Michael Sundberg; Lúcia Passos; André Luiz Muniz; Silvane Santos
Journal:  Case Rep Neurol Med       Date:  2012-08-16

10.  Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.

Authors:  Bruno Caetano Trindade; Carlos Artério Sorgi; Larissa Deadame de Figueiredo Nicolete; Tathiane Maistro Malta; Mariana Tomazini Pinto; Osvaldo Massaiti Takayanagui; Dimas Tadeu Covas; Olindo Assis Martins Filho; Simone Kashima; Lúcia Helena Faccioli
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.